DeLand, Florida— March 10, 2010 — Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, Florida, announces the launch of several tobacco consumers clinical trials to test investigational treatment options for those who use SNUS, chew, or dip and have no intention of quitting. “We are very pleased to begin the systemic evaluation of our research studies regarding tobacco consumers and their strong desires to us these types of tobacco products,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on tobacco consumers.” Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.
The research studies will enroll those who are current tobacco users, and in order to participate in the studies volunteers must be users of SNUS (pronounced – ’snooze’), chew, or dip. In addition they should have the no desire to quit using either of these products.
Avail Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. For more information regarding participation in our clinical trials, contact Avail Clinical Research at 386.310.1334, or at www.AvailClinical.com.


